![]()
|
|
||||||||
(Received for publication, June 19, 1996, and in revised form, September 9, 1996)
From the Department of Biochemistry, Tokyo Women's Medical
College, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162, Japan and
Protein 4.1 is an important structural component
of the erythrocyte membrane. In contrast to our detailed understanding
of the role of protein 4.1 in regulating membrane mechanical properties through modulation of spectrin-actin interaction, very little is known
regarding the functional implications of protein 4.1 interaction with
band 3. In the present study, we explored the potential role of protein
4.1-band 3 interaction in modulating membrane mechanical properties.
Based on recent studies which identified the sequence motif IRRRY in
band 3 as the protein 4.1 interacting domain, we studied the functional
consequences of specific dissociation of band 3-protein 4.1 interaction
by the synthetic peptide IRRRY. We show that protein 4.1 bound to the inside-out vesicles could be dissociated from band 3 but not from glycophorin C by IRRRY. Furthermore, incorporation of IRRRY into resealed ghosts resulted in decreased membrane deformability and increased membrane mechanical stability. The observed alterations in
membrane properties appears to result from increased band 3-ankyrin interaction following dissociation of protein 4.1 from band 3. These
studies have enabled us to identify an important functional role for
band 3-protein 4.1 interaction in modulating erythrocyte membrane
properties.
Mechanical properties of the human erythrocyte membrane are
primarily regulated by the spectrin-based membrane skeleton that underlies the lipid bilayer and by membrane proteins that anchor the
skeleton to the bilayer (for review, see Ref. 1). Spectrin, actin,
protein 4.1, adducin, tropomyosin, tropomodulin, dematin, and p55 are
the principal constituents of the membrane skeleton. Lateral
interactions among these proteins constitute the composite structure
designated as the membrane skeletal network. This network is anchored
to the bilayer through vertical interactions, one involving
Recent biochemical studies of the purified protein, together with
molecular cloning and sequencing of the 4.1 cDNA, have facilitated construction of a structure and functional map of erythrocyte protein
4.1 molecule (4). Four major structural domains of protein 4.1 with
apparent molecular masses of 30, 16, 10, and 22-24 kDa were identified
(5). Purified erythrocyte protein 4.1 has been shown to bind with high
affinity to spectrin and with lower affinity to actin through its
10-kDa domain (6, 7, 8, 9, 10). Protein 4.1 interacts with integral membrane proteins band 3 (11, 12, 13, 14) and glycophorin C (15, 16, 17, 18) through its 30-kDa
domain.
Direct evidence for a critical role for protein 4.1 in maintaining
membrane mechanical stability was demonstrated by studies in which
normal membrane mechanical stability was restored to the unstable
protein 4.1-deficient erythrocyte membranes through incorporation of
either purified protein 4.1 (19) or the 10-kDa spectrin-actin binding
domain of protein 4.1 (20). In contrast to our detailed understanding
of the role of protein 4.1 in regulating membrane mechanical properties
through modulation of spectrin-actin interactions, very little is known
regarding the functional implications of protein 4.1 interaction with
band 3.
In the present study, we explored the potential role of protein
4.1-band 3 interaction in modulating membrane mechanical properties by
studying the functional consequences of specific dissociation of band
3-protein 4.1 interaction using the synthetic peptide IRRRY (21). We
were able to show that protein 4.1 bound to the inside-out vesicles
(IOVs)1 could be dissociated from band 3 but not from glycophorin C by IRRRY. Furthermore, incorporation of
IRRRY into resealed ghosts resulted in decreased membrane deformability
and increased membrane mechanical stability. The observed alterations
in membrane properties appear to result from increased band 3-ankyrin
interaction following dissociation of protein 4.1 from band 3. These
studies have enabled us to identify an important functional role for
band 3-protein 4.1 interaction in modulating erythrocyte membrane
properties.
Materials
After obtaining informed consent, human venous blood was freshly
drawn from healthy volunteers. Various synthetic peptides were
synthesized by the Fmoc (N-(9-fluorenyl)methyloxycarbonyl) method and purified by reverse phase high performance liquid
chromatography (24). Trypsin (type 1 from bovine pancreas) and trypsin
inhibitor (type 1-S from soybean) were purchased from
Sigma. Protein 4.1 and ankyrin were purified according
to the method developed by Tyler et al. (6) with minor
modifications. These purified proteins were labeled using Bolton-Hunter
reagent (2000 Bq/mmol, DuPont NEN) and were dialyzed against 100 mM KCl, 2 mM MgCl2, 1 mM dithiothreitol, 5 mM sodium phosphate, pH
7.4, 1 mM NaN3, and 1 mg/ml bovine serum albumin (the binding buffer).
Methods
Inside-out vesicles depleted of all
peripheral proteins (pH 11 IOV) and trypsin-digested pH 11 IOV (T-pH 11 IOV) were prepared according to methods described by Danilov et
al. (12) with minor modifications. SDS-polyacrylamide gel
electrophoresis analysis of T-pH 11 IOVs showed that the cytoplasmic
domain of band 3 was completely digested in this IOV preparation. In
contrast, the cytoplasmic domain of glycophorin C remained intact.
125I-protein 4.1 (330 µg) was incubated
separately with pH 11 IOV (300 µg) and T-pH 11 IOV (300 µg) in 1 ml
of the binding buffer for 1 h at 24 °C. IOVs were collected by
centrifugation and washed three times to remove unbound
125I-protein 4.1. Peptides IRRRY or FGGLVRD at various
concentrations were added to 125I-protein 4.1-reconstituted
IOVs (30 µg) and incubated at 37 °C for 40 min. Following
incubation, the mixture was layered onto 200 µl of 8% sucrose
cushion in binding buffer and centrifuged at 12500 × g
for 30 min at 4 °C. IOVs were collected and the amount of
125I-protein 4.1 bound to IOVs was quantitated using a
gamma counter. Amount of 125I-protein 4.1 bound to
denatured IOVs was determined to quantitate nonspecific binding.
Nonspecific binding constituted approximately 3% of total binding and
was subtracted from the measured values to derive the specific binding.
Data shown are the mean of triplicate measurements.
Washed
erythrocytes were lysed in 35 volumes of hypotonic buffer (5 mM Tris, 5 mM KCl, pH 7.4) at 4 °C and
washed four times. The white membranes were incubated at 0 °C for 10 min with synthetic peptides at various concentrations with gentle
stirring. A small volume of a mixture of KCl, MgCl2, and
dithiothreitol and trypsin inhibitor was added to the membrane
suspensions to obtain final concentrations of 150 mM, 1 mM, and 1 mM and 1.7 mg/ml, respectively, and
the ghost suspensions incubated at 37 °C for 40 min to allow membrane resealing (25).
The resealed
ghosts were suspended in 45% dextran, and membrane mechanical
stability was quantitated using an ektacytometer as described
previously (25, 26). The rate of decrease of deformability index (DI)
at a constant applied shear stress of 750 dynes/cm2 was
analyzed to quantitate membrane mechanical stability (25, 26). To
measure membrane deformability, resealed ghosts were suspended in
Stractan (22 centipoise viscosity, 290 mosm) and exposed to an
increasing shear stress (0-150 dynes/cm2) in the
ektacytometer. DI versus applied shear stress curve was analyzed to quantitate membrane deformability (26).
Binding of 125I-ankyrin to the cytoplasmic
domain of band 3 was quantitated according to the method described by
Bennett et al. (22). Briefly, 125I-ankyrin at
various concentrations was incubated with pH 11 IOVs or pH 11 IOVs
previously preincubated with protein 4.1 in the binding buffer at
24 °C for 3 h. The mixture was layered onto 8% sucrose
cushion, centrifuged at 4 °C, IOVs collected, and the amount of
bound 125I-ankyrin determined using a gamma counter.
To
document that the synthetic peptide IRRRY can selectively dissociate
protein 4.1 from band 3 without affecting protein 4.1-glycophorin C
interaction, pH 11 IOVs and T-pH 11 IOVs were first reconstituted with
125I-protein 4.1 and subsequently incubated with increasing
concentrations of the peptide, and the release of bound protein 4.1 was
monitored (Fig. 1). 194 µg of protein 4.1/mg of
vesicle proteins bound to band 3 and glycophorin C on pH 11 IOVs, while
98 µg of protein 4.1/mg of vesicle proteins bound to glycophorin C on
T-pH 11 IOVs. These measured values are in excellent agreement with
results previously reported for protein 4.1 binding to IOVs (11, 12, 13, 14).
Incubation with increasing concentrations of IRRRY resulted in a
dose-dependent displacement of bound protein 4.1 from pH 11 IOVs (Fig. 1). At an IRRRY concentration of 6 mM, only 100 µg of protein 4.1/mg of vesicle proteins remained associated with the
pH 11 IOVs compared to 194 µg of protein 4.1/mg of vesicle proteins
associated with IOVs in the absence of the peptide. In marked contrast,
IRRRY did not displace bound protein 4.1 from T-pH 11 IOVs (Fig. 1).
The finding that IRRRY decreased the amount of protein 4.1 bound to pH
11 IOVs to the same levels as that found normally bound to T-pH 11 IOV
(98 µg of protein 4.1/mg of vesicle proteins) implies that IRRRY
specifically dissociated 125I-protein 4.1 bound to band 3 but has no effect on protein 4.1 binding to glycophorin C. In contrast
to IRRRY, the control peptide FGGLVRD did not release bound protein 4.1 from pH 11 IOVs (data not shown). To further validate the specificity
of IRRRY in regulating band 3-protein 4.1 interaction, the ability of
this peptide to dissociate ankyrin from band 3 was assessed. In
contrast to our findings with protein 4.1 reconstituted vesicles, IRRRY
was not able to release 125I-ankyrin from band 3 in ankyrin
reconstituted pH 11 IOVs (data not shown).
To determine the functional consequences of
dissociation of band 3-protein 4.1 interaction, membrane deformability
and mechanical stability of erythrocytes ghosts reconstituted with
different synthetic peptides were measured. Representative data for
membrane mechanical stability of ghosts prepared in the presence and
absence of the peptide IRRRY are shown in Fig.
2A. IRRRY caused a dose-dependent increase in membrane mechanical stability as revealed by slower rates
of decline in the deformability index of peptide reconstituted ghosts
compared to control ghosts. Membranes of ghosts reconstituted with
IRRRY at 2 mM were 1.5 times more stable than membranes of control ghosts, while ghosts reconstituted with IRRRY at 5 mM were 2.6 times more stable. IRRRY incorporation into
ghosts also resulted in decreased membrane deformability (Fig.
2B) as revealed by the higher levels of applied shear stress
needed to produce an equivalent increase in deformability index of
these ghosts compared to control ghosts. Membrane deformability of
ghosts reconstituted with IRRRY at 2 mM was decreased
2-fold, while deformability of ghosts reconstituted with IRRRY at 5 mM decreased 3.2-fold. Neither membrane mechanical
stability nor membrane deformability was altered following resealing of
the ghosts with the control peptide FGGLVRD (data not shown).
Incorporation of either of the peptides also had no effect on shape of
resealed ghosts (data not shown).
To confirm that entrapment of IRRRY into the ghosts is essential for
its observed effects on membrane mechanical properties, IRRRY was added
to resealed ghosts so that the peptide could have access only to the
outer surface of the membranes and not to the cytoplasmic domain of
band 3. Addition of 6 mM IRRRY to resealed ghosts did not
induce changes in either membrane mechanical stability or membrane
deformability (data not shown), implying that the effect of IRRRY on
membrane properties is due to its effect on the cytoplasmic side of the
membrane. As an additional control, we measured the effects of
incorporating into ghosts IRRRY bound to purified protein 4.1. IRRRY-bound protein 4.1 up to a concentration of 175 µg/ml did not
induce changes in either deformability or mechanical stability of
resealed ghosts (data not shown), implying that the observed
IRRRY-induced changes in membrane properties are due to peptide-induced
dissociation of protein 4.1 from band 3 and not due to direct membrane
effects of the dissociated IRRRY-bound protein 4.1.
To define the structural requirement of peptide involved in mediating
membrane changes, we evaluated the effect of a number of additional
peptides on membrane mechanical properties. In addition to IRRRY,
peptides YRRRI and IRRRI also induced decreases in membrane deformability and increases in mechanical stability (data not shown).
In contrast, peptides IRLRY and IRARY did not affect either deformability or mechanical stability of resealed membranes.
To determine
whether the IRRRY-induced functional changes in erythrocyte membrane
are the result of changes in the affinity of band 3-ankyrin interaction
following dissociation of protein 4.1 from band 3 we quantitated
ankyrin binding to native pH 11 IOVs and pH 11 IOVs previously
preincubated with various concentrations of protein 4.1 (Fig.
3A). Scatchard analysis of ankyrin binding (Fig. 3B) to native IOVs showed high (Kd = 4.94 × 10
Effect of protein 4.1 on ankyrin binding to IOV
Volume 271, Number 52,
Issue of December 27, 1996
pp. 33187-33191
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
FUNCTIONAL IMPLICATIONS IN REGULATION OF ERYTHROCYTE
MEMBRANE MECHANICAL PROPERTIES*
§
Life Sciences Division, Lawrence Berkeley National
Laboratory, University of California, Berkeley,
California 94720
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
-spectrin, ankyrin, and band 3, and the other through an interaction
between protein 4.1 and glycophorin C (for review, see Refs. 2 and
3).
Dissociation of Membrane-bound Protein 4.1 by IRRRY
Fig. 1.
Dissociation of membrane-bound protein 4.1 from IOVs by synthetic peptide IRRRY. pH 11 IOVs and T-pH 11 IOVs
were first reconstituted with 125I-protein 4.1 and
subsequently incubated at 37 °C for 40 min with varying
concentrations of IRRRY. Following incubation, the IOVs were collected
and 125I-protein 4.1 remaining bound to pH 11 IOVs (
)
and T-pH 11 IOVs (
) was counted using a gamma counter.
125I-protein 4.1 was displaced from pH 11 IOVs by
increasing concentrations of IRRRY. In contrast, IRRRY did not displace
protein 4.1 from T-pH 11 IOVs. Protein 4.1 displaced from pH 11 IOVs
represents the fraction that is bound to band 3.
[View Larger Version of this Image (17K GIF file)]
Fig. 2.
Effects of incorporation of IRRRY into
erythrocyte ghosts on membrane mechanical properties. Membrane
mechanical stability (A) and membrane deformability
(B) of ghosts resealed with increasing concentrations of
IRRRY were measured using an ektacytometer. A, membrane
mechanical stability quantitated by the rate of decline in DI is slower
for ghosts resealed with IRRRY (DI curve shifted to the right),
indicating that incorporation of IRRRY into ghosts mechanically
stabilized these membranes. B, membrane deformability quantitated by the slope of DI versus shear stress curve is
lower for ghosts resealed with IRRRY, indicating decreased membrane deformability (increased membrane rigidity). The extent of decrease in
membrane deformability and of increase in mechanical stability were
dependent on concentrations of IRRRY incorporated into ghosts.
[View Larger Version of this Image (21K GIF file)]
8 M) and low
(Kd = 10.8 × 10
8 M)
affinity phases of association in the absence of protein 4.1 (Table
I), consistent with the data of Bennett et
al. (22), Davis and Bennett (23), and Low et al. (27).
The total binding capacity of ankyrin to band 3 was 181 µg/mg of
vesicle proteins corresponding to a molar ratio of one ankyrin per five
to six band 3 monomers. Based on extrapolation of the Scatchard plot in
Fig. 3B, the binding capacities of high and low affinity
binding sites were estimated to be 72 and 109 µg/mg, respectively.
When band 3 on pH 11 IOV was previously half-saturated with protein 4.1, the binding capacity of high affinity sites decreased to 44 µg/mg, while the total binding capacity remained unchanged (Table I)
through an increase in binding capacity contributed by low affinity
binding sites. Complete saturation of band 3 with protein 4.1 resulted
in almost a complete loss of ankyrin binding to band 3 through the high
affinity binding sites (16 µg/mg), while the total binding capacity
once again remained unchanged (Table I). Thus while protein 4.1 binding
to band 3 had little or no effect on the total binding capacity of
ankyrin to band 3, it had significant effect on relative contributions
of high and low affinity sites for ankyrin binding. Protein 4.1 binding to band 3 thus appears to play a significant role in modulating the
affinities of ankyrin association with band 3.
Fig. 3.
Effects of protein 4.1 on ankyrin binding to
band 3. A, 125I-ankyrin at various
concentrations was incubated with 30 µg of pH 11 IOVs in the absence
(
) or presence of protein 4.1 at concentrations of 79 (
) and 198 (
) µg of protein 4.1/mg of IOV-protein. The amount of
125I-ankyrin bound to IOVs was quantitated. B,
Scatchard analysis of ankyrin binding data shown in A. There
is a marked decrease in the contribution of high affinity ankyrin
binding sites to total binding in the presence of protein 4.1.
[View Larger Version of this Image (17K GIF file)]
Protein 4.1/IOV
Kd
(×10
8 M)Binding capacity
High
Low
High
Low
Total
µg/mg
µg/mg
0
4.94
10.8
72
109
181
79
4.94
37.5
44
148
192
198
4.05
67.6
16
176
192
An important structural role for protein 4.1 in regulating erythrocyte membrane properties through its interaction with spectrin and actin has been previously established. Biochemical studies have documented that in addition to its interactions with spectrin and actin, protein 4.1 also interacts with p55, calmodulin, glycophorin C, and band 3. However, the functional consequences of these other interactions of protein 4.1 have not been well delineated. The present study enabled us to document a hitherto unrecognized role for protein 4.1 in regulating membrane mechanical properties through modulation of the ankyrin-band 3 interaction.
Jons and Drenckhahn (21) showed that arginine-rich cluster IRRRY in the cytoplasmic domain of band 3 serves as the major binding site for protein 4.1. Their study indicated that the binding of protein 4.1 to band 3 and to IOVs can be inhibited by synthetic peptides IRRRY and FGGLVRDIRRRY but not by the peptide FGGLVRD. Based on these findings, we explored the use of synthetic peptide IRRRY to dissociate protein 4.1 from band 3 and determining the functional consequences of modifying band 3-protein 4.1 interaction. IRRRY indeed selectively dissociated protein 4.1 from band 3 but had no effect on protein 4.1 interaction with glycophorin C or on interaction of ankyrin with band 3. IRRRY induced dissociation of protein 4.1 from band 3 resulted in marked alterations in membrane mechanical properties. Furthermore, our finding that peptides YRRRI and IRRRI induced membrane alteration similar to IRRRY, while peptides IRLRY and IRARY had no effect on membrane properties suggests that the sequence motif XRRRX may be critical for mediating the interaction of cytoplasmic domain of band 3 with protein 4.1.
Our finding that 50% of total protein 4.1 bound to IOVs is displaced by IRRRY is consistent with previous reports which showed that 50% of membrane-bound protein 4.1 is linked to band 3 (11, 12, 13, 14). These findings, however, are at variance with the findings of Hemming et al. (17), who reported using a solid phase binding assay that only 20% of protein 4.1 is bound to band 3. Our finding that IRRRY is able to specifically displace 50% of membrane-bound protein 4.1 from normal IOVs (binding to both band 3 and glycophorin C) but has no effect of membrane-bound protein 4.1 in trypsin-treated IOVs (binding only to glycophorin C) implies that band 3 indeed accounts for half of membrane-bound protein 4.1.
The functional data on membrane properties we have outlined clearly show that dissociation of protein 4.1 from band 3 induces marked decreases in membrane deformability and marked increases in membrane mechanical stability. As band 3-ankyrin interaction plays an important role in regulating membrane mechanical properties (28) and band 3 can bind to both ankyrin and protein 4.1, we explored the possibility that alterations in band 3-ankyrin interaction following dissociation of protein 4.1 from band 3 may be responsible for observed membrane functional changes. We could indeed document significant differences in the binding of ankyrin to band 3 in the presence or absence of protein 4.1. In the absence of protein 4.1, ankyrin associates with both high and low affinity sites on band 3, consistent with previous findings of Bennett et al. (22), Davis and Bennett (23), and Low et al. (27). Either different oligomeric states or different conformations of band 3 is responsible for both classes of ankyrin binding sites. In fact, Michaely and Bennett (29) have recently shown that the interaction of ankyrin with erythrocyte membranes has negative cooperativity. One possible explanation for our finding that binding of protein 4.1 to band 3 induces a marked decrease in the contribution of high affinity binding sites could be that protein 4.1 binding induces conformational changes in band 3, resulting in the transformation of high affinity binding sites to low affinity sites. The alternative possibility is that cooperativity of ankyrin binding to band 3 was abolished by protein 4.1 binding to band 3.
These biochemical studies shed insights into the mechanistic basis for the observed changes in membrane material properties. A number of recent studies have outlined convincing evidence that increased interaction of the cytoplasmic domain of band 3 can induce marked decreases in membrane deformability, while decreased association leads to membrane instability. For example, increased association of the cytoplasmic domain of band 3 has been shown to account for decreased membrane deformability of Southeast Asian ovalocytosis (30) and of normal erythrocyte membranes following binding of specific antibodies to either glycophorin A or band 3 (31). Dissociation of band 3 from ankyrin using either alkaline pH conditions (28) or by incorporation of the band 3-binding domain of ankyrin into resealed ghosts (32) has been shown to result in marked decreases in membrane mechanical stability. Also the marked membrane instability of both mouse (33) and bovine (34) red cells with complete deficiency of band 3 imply an important structural role for band 3 in regulating membrane material properties. Based on these findings, we propose the following mechanism for the observed changes in membrane material properties during the present study: dissociation of protein 4.1 from band 3 promotes high affinity ankyrin-band 3 interaction, which in turn results in increased association of band 3 with the skeletal network. This increased association restricts the ability of the spectrin tetramers to uncoil and extend during induced deformation resulting in decreased membrane deformability and increased membrane mechanical stability. These results further confirm an important role for band 3-ankyrin interaction in regulation of membrane mechanical properties.
Previous studies provided significant insights into the important contribution of protein 4.1 in regulating erythrocyte membrane function through its interaction with skeletal proteins spectrin and actin. The present study shows an additional role for protein 4.1 in modulating membrane function by regulating ankyrin-band 3 interactions. These results also raise the possibility that protein 4.1, which is widely expressed in various cells, may regulate the organization and function of other ankyrin-linked integral membrane proteins.
We thank Dr. Hiroaki Horikawa for useful discussions and Naoko Miyama for technical assistance.
This article has been cited by other articles:
![]() |
N. Terada, N. Ohno, S. Saitoh, G. Seki, M. Komada, T. Suzuki, H. Yamakawa, M. Soleimani, and S. Ohno Interaction of Membrane Skeletal Protein, Protein 4.1B and p55, and Sodium Bicarbonate Cotransporter1 in Mouse Renal S1-S2 Proximal Tubules J. Histochem. Cytochem., December 1, 2007; 55(12): 1199 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Anong, T. L. Weis, and P. S. Low Rate of Rupture and Reattachment of the Band 3-Ankyrin Bridge on the Human Erythrocyte Membrane J. Biol. Chem., August 4, 2006; 281(31): 22360 - 22366. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. G. Mayer, L. Jiang, R. N. Achur, I. Kakizaki, D. C. Gowda, and L. H. Miller The glycophorin C N-linked glycan is a critical component of the ligand for the Plasmodium falciparum erythrocyte receptor BAEBL PNAS, February 14, 2006; 103(7): 2358 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tiffert, V. L. Lew, H. Ginsburg, M. Krugliak, L. Croisille, and N. Mohandas The hydration state of human red blood cells and their susceptibility to invasion by Plasmodium falciparum Blood, June 15, 2005; 105(12): 4853 - 4860. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mandal, V. Baudin-Creuza, A. Bhattacharyya, S. Pathak, J. Delaunay, M. Kundu, and J. Basu Caspase 3-mediated Proteolysis of the N-terminal Cytoplasmic Domain of the Human Erythroid Anion Exchanger 1 (Band 3) J. Biol. Chem., December 26, 2003; 278(52): 52551 - 52558. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhang, A. Kiyatkin, J. T. Bolin, and P. S. Low Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3 Blood, November 1, 2000; 96(9): 2925 - 2933. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Nunomura, Y. Takakuwa, M. Parra, J. G. Conboy, and N. Mohandas Ca2+-dependent and Ca2+-independent Calmodulin Binding Sites in Erythrocyte Protein 4.1. IMPLICATIONS FOR REGULATION OF PROTEIN 4.1 INTERACTIONS WITH TRANSMEMBRANE PROTEINS J. Biol. Chem., February 25, 2000; 275(9): 6360 - 6367. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Parra, P. Gascard, L. D. Walensky, J. A. Gimm, S. Blackshaw, N. Chan, Y. Takakuwa, T. Berger, G. Lee, J. A. Chasis, et al. Molecular and Functional Characterization of Protein 4.1B, a Novel Member of the Protein 4.1 Family with High Level, Focal Expression in Brain J. Biol. Chem., February 4, 2000; 275(5): 3247 - 3255. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tominaga and D. L. Barber Na-H Exchange Acts Downstream of RhoA to Regulate Integrin-induced Cell Adhesion and Spreading Mol. Biol. Cell, August 1, 1998; 9(8): 2287 - 2303. [Abstract] [Full Text] |
||||
![]() |
R. F. Workman and P. S. Low Biochemical Analysis of Potential Sites for Protein 4.1-mediated Anchoring of the Spectrin-Actin Skeleton to the Erythrocyte Membrane J. Biol. Chem., March 13, 1998; 273(11): 6171 - 6176. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Nunomura, Y. Takakuwa, R. Tokimitsu, S. W. Krauss, M. Kawashima, and N. Mohandas Regulation of CD44-Protein 4.1 Interaction by Ca2+ and Calmodulin. IMPLICATIONS FOR MODULATION OF CD44-ANKYRIN INTERACTION J. Biol. Chem., November 28, 1997; 272(48): 30322 - 30328. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Nunomura, Y. Takakuwa, M. Parra, J. Conboy, and N. Mohandas Regulation of Protein 4.1R, p55, and Glycophorin C Ternary Complex in Human Erythrocyte Membrane J. Biol. Chem., August 4, 2000; 275(32): 24540 - 24546. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. An, Y. Takakuwa, S. Manno, B.-G. Han, P. Gascard, and N. Mohandas Structural and Functional Characterization of Protein 4.1R-Phosphatidylserine Interaction. POTENTIAL ROLE IN 4.1R SORTING WITHIN CELLS J. Biol. Chem., September 14, 2001; 276(38): 35778 - 35785. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou and P. S. Low Characterization of the Reversible Conformational Equilibrium in the Cytoplasmic Domain of Human Erythrocyte Membrane Band 3 J. Biol. Chem., October 5, 2001; 276(41): 38147 - 38151. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Manno, Y. Takakuwa, and N. Mohandas Identification of a functional role for lipid asymmetry in biological membranes: Phosphatidylserine-skeletal protein interactions modulate membrane stability PNAS, February 19, 2002; 99(4): 1943 - 1948. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |